Sofinnova Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
BiotechGaithersburg, US
Gregory L. Merril(Executive Officer, Director, Promoter)Carl R. Merril(Executive Officer, Director)
BoardEvan Loh(Director)Jana Jensen(Director)Raymond L. Martz(Director)
Board seatJonathan Leff· per SEC Form D · $30M raise · filed Jun 2023
Co-investorsAMR Action Fund
Avalyn Pharma (formerly Genoa Pharmaceuticals) is a biopharma company developing inhaled therapies for idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.
BiotechHealthtechSan Diego, US
Mark W. Surber, Ph.D.(Executive Officer, Director)Richard G. Vincent(Executive Officer)
BoardMichael J. Kamdar(Director)Daniel D. Burgess(Director)
Board seatJonathan Leff· per SEC Form D · $189.2M raise · filed Oct 2023
Co-investorsNorwest Venture PartnersRiverVest Venture Partners
Seattle, US
Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)
BoardRobert Shepler(Director)in
Board seatDavid Kabakoff· per SEC Form D · $35.7M raise · filed Jul 2023
Co-investors5AM VenturesArboretum VenturesF-Prime CapitalTelegraph Hill Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.